These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14993620)

  • 1. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.
    Corbett Y; Herrera L; Gonzalez J; Cubilla L; Capson TL; Coley PD; Kursar TA; Romero LI; Ortega-Barria E
    Am J Trop Med Hyg; 2004 Feb; 70(2):119-24. PubMed ID: 14993620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro.
    Quashie NB; de Koning HP; Ranford-Cartwright LC
    Malar J; 2006 Oct; 5():95. PubMed ID: 17076900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening.
    Sanchez BA; Varotti FP; Rodrigues FG; Carvalho LH
    J Microbiol Methods; 2007 Jun; 69(3):518-22. PubMed ID: 17466399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.
    Rason MA; Randriantsoa T; Andrianantenaina H; Ratsimbasoa A; Menard D
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):346-51. PubMed ID: 18321546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.
    Kosaisavee V; Suwanarusk R; Nosten F; Kyle DE; Barrends M; Jones J; Price R; Russell B; Lek-Uthai U
    Exp Parasitol; 2006 Sep; 114(1):34-9. PubMed ID: 16545375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High-Resolution Melting analysis.
    Andriantsoanirina V; Lascombes V; Ratsimbasoa A; Bouchier C; Hoffman J; Tichit M; Rabarijaona LP; Durand R; Ménard D
    J Microbiol Methods; 2009 Aug; 78(2):165-70. PubMed ID: 19465064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The microfluorimetric assay (MFA) in in vitro testing the sensitivity of Plasmodium falciparum to antimalarial drugs].
    Huang F; Tang LH; Wang QM; Hi YC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):41-4. PubMed ID: 16866142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytes.
    Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
    Malar J; 2009 Dec; 8():279. PubMed ID: 19961586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial activity of natural product extracts from Papua New Guinean and Australian plants against Plasmodium falciparum.
    Fernandez LS; Jobling MF; Andrews KT; Avery VM
    Phytother Res; 2008 Oct; 22(10):1409-12. PubMed ID: 18693292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of antimalarial activity for new compounds by isotopic microtest].
    Chen ZG; Moreno A; Benito A; Moreno M; Berzosa PJ; de Lucio A; Moyano E
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb; 27(1):83-6. PubMed ID: 19459510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro assay system for the identification of potential antimalarial drugs.
    Geary TG; Divo AA; Jensen JB
    J Parasitol; 1983 Jun; 69(3):577-83. PubMed ID: 6355423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives.
    Noedl H; Wernsdorfer WH; Kollaritsch H; Looareesuwan S; Miller RS; Wongsrichanalai C
    Wien Klin Wochenschr; 2003; 115 Suppl 3():23-7. PubMed ID: 15508776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antimalarial drugs on Plasmodium falciparum gametocytes.
    Peatey CL; Skinner-Adams TS; Dixon MW; McCarthy JS; Gardiner DL; Trenholme KR
    J Infect Dis; 2009 Nov; 200(10):1518-21. PubMed ID: 19848586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.
    Johnson JD; Dennull RA; Gerena L; Lopez-Sanchez M; Roncal NE; Waters NC
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1926-33. PubMed ID: 17371812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer.
    Izumiyama S; Omura M; Takasaki T; Ohmae H; Asahi H
    Exp Parasitol; 2009 Feb; 121(2):144-50. PubMed ID: 19017530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-plasmodial activity of the extracts of some Kenyan medicinal plants.
    Rukunga GM; Gathirwa JW; Omar SA; Muregi FW; Muthaura CN; Kirira PG; Mungai GM; Kofi-Tsekpo WM
    J Ethnopharmacol; 2009 Jan; 121(2):282-5. PubMed ID: 19041710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.